ClinicalTrials.gg

Program

Prilocaine

Also written as “Tested Lidocaine and Prilocaine Cream” and “lidocaine and prilocaine”.

Its studies are mostly in Periodontal Diseases, led by 2 companies.

Furthest: phase 4, since Jun 24, 20112 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Dentsply Sirona10 open or runningphase 4since Jun 24, 2011Jun 24, 2011none ahead
Haisco Pharmaceutical Group10 open or runningphase 1since Apr 20, 2026Apr 20, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 24, 2011First study: phase 4 study in Periodontal DiseasesNew to Dentsply SironaDentsply Sirona · NCT01591616 · 16 enrolled · United States
  2. Apr 20, 2026Haisco Pharmaceutical Group’s first study: phase 1 study in HealthyNew to Haisco Pharmaceutical GroupHaisco Pharmaceutical Group · NCT07551713 · 40 enrolled · China

TargetBeta

“Sodium channel alpha subunit blocker; Sodium channel alpha subunit blocker”ChEMBL 37, by rule

Other programs on the same 10 targets

ProgramCompanyFurthest phaseStudies
LidocaineruleKeenova Therapeuticsphase 463
LamotrigineruleGlaxoSmithKlinephase 461
Carbamazepinerulegrin-therapeutics-incphase 421
DronedaroneruleSanofiphase 418
chloroprocainerulesintetica-saphase 48
RiluzoleruleSanofiphase 46
CarticaineruleLaboratoires Theaphase 41
Ropivacainerulepainreform-ltdphase 317
PhenytoinruleViatrisphase 310
rufinamideruleEisaiphase 37

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07551713Healthy · China1CompletedHaisco Pharmaceutical GroupJul 10, 202040
NCT01591616Periodontal Diseases · United States4CompletedDentsply SironaApr 201216

How it is read

Names in the registry

  • “Tested Lidocaine and Prilocaine Cream”, 1 entry
  • “lidocaine and prilocaine”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.